About Qairn
Qairn is a company based in Paris (France) founded in 2020 by Paul-Antoine Tremolet and Francois Cancelloni. Qairn has raised $1.43 million across 1 funding round. Qairn offers products and services including UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie. Qairn operates in a competitive market with competitors including Datapharm, RXTransparent, TraceMed, PharmaQR and Trievr, among others.
- Headquarter Paris, France
- Founders Paul-Antoine Tremolet, Francois Cancelloni
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.43 M (USD)
in 1 rounds
-
Latest Funding Round
$1.43 M (USD), Seed
Jul 21, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qairn
Qairn offers a comprehensive portfolio of products and services, including UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie.
Software for examining and validating promotional documents in health regulations.
Tool for handling advantages and compliance in health sector processes.
Platform for managing medical data and regulatory submissions efficiently.
Educational tools for learning regulatory automation in healthcare.
Funding Insights of Qairn
Qairn has successfully raised a total of $1.43M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.43 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Qairn
Investment portfolio details for Qairn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qairn
Detailed financials for Qairn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qairn Comparisons
Peer comparison for Qairn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qairn
Qairn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Datapharm, RXTransparent, TraceMed, PharmaQR and Trievr, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regulatory compliance software for pharma and healthcare professionals is provided.
|
|
| Locked | Locked | Locked |
Cloud-based supply chain software for pharmacies is provided.
|
|
| Locked | Locked | Locked |
Offers e-verification software for pharmacies and hospitals to ensure compliance.
|
|
| Locked | Locked | Locked |
Offers cloud-based solutions for regulatory compliance in pharmacy.
|
|
| Locked | Locked | Locked |
Request management platform for pharma compliance, audits, and recalls.
|
Detailed competitors of Qairn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qairn
Complete news archive for Qairn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qairn
Qairn was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Qairn is headquartered in Paris, France.
Qairn is a funded company, having raised a total of $1.43M across 1 funding round to date.
Qairn was established in 2020 and is headquartered in Paris, France. Solutions focused on regulatory and compliance management for pharmaceutical laboratories are delivered. Workflow automation for regulatory documents is enabled, alongside electronic signature management and audit trailing of documents. Operations support document handling and oversight within the pharmaceutical sector, ensuring adherence to standards.
Qairn's top competitors include Datapharm, RXTransparent and PharmaQR.
Qairn offers UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie.